Abstract
Overall survival (OS), disease-free survival (DFS), and distant recurrence-free interval (DRFI) were evaluated from 169 patients diagnosed with early triple negative breast cancer. Overall, 5 and 10 years OS, DFS, and DRFI were 77% and 65%; 60% and 46%; and 74% and 73%, respectively. Forty-seven patients did not receive chemotherapy. A separate analysis was performed excluding those patients. In this subgroup, 5- and 10-year OS, DFS, and DRFI were 86% and 77%; 68% and 54%, 77% both at 5 and 10 years. Prognosis is better than previously described; adjuvant chemotherapy should be offered to fit elderly patients if clinically warranted.
Original language | English |
---|---|
Pages (from-to) | 1225-1229 |
Number of pages | 5 |
Journal | The Breast Journal |
Volume | 25 |
Issue number | 6 |
DOIs | |
Publication status | Published - Nov 2019 |
Externally published | Yes |
Keywords
- breast cancer
- elderly
- outcome
- prognosis
- triple negative